Atlas Trials

Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B

Clinical trial NCT07328711 · RECRUITING

Trial details

NCT number
NCT07328711
Sponsor
Peking University People's Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Chronic Hepaititis B
Start date
2026-01-01
Primary completion
2028-12-31
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.